Cargando…
Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease
BACKGROUND: To evaluate prescription trends and clinical factors of the sodium-glucose cotransporter 2 inhibitors (SGLT2i) use according to the presence of atherosclerotic cardiovascular disease (ASCVD) or heart failure (HF) in Korean patients with type 2 diabetes mellitus (T2DM). METHODS: Prescript...
Autores principales: | Baek, Jong Ha, Yang, Ye Seul, Ko, Seung-Hyun, Han, Kyung Do, Kim, Jae Hyeon, Moon, Min Kyong, Park, Jong Suk, Lee, Byung-Wan, Oh, Tae Jung, Chon, Suk, Choi, Jong Han, Hur, Kyu Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532175/ https://www.ncbi.nlm.nih.gov/pubmed/35654585 http://dx.doi.org/10.4093/dmj.2022.0002 |
Ejemplares similares
-
Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: a Korean Diabetes Association and Korean Society of Nephrology consensus statement
por: Oh, Tae Jung, et al.
Publicado: (2020) -
Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
por: Oh, Tae Jung, et al.
Publicado: (2020) -
Comprehensive Understanding for Application in Korean Patients with Type 2 Diabetes Mellitus of the Consensus Statement on Carbohydrate-Restricted Diets by Korean Diabetes Association, Korean Society for the Study of Obesity, and Korean Society of Hypertension
por: Choi, Jong Han, et al.
Publicado: (2022) -
Comparison of Operational Definition of Type 2 Diabetes Mellitus Based on Data from Korean National Health Insurance Service and Korea National Health and Nutrition Examination Survey
por: Baek, Jong Ha, et al.
Publicado: (2023) -
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Korean Patients with Type 2 Diabetes Mellitus in Real-World Clinical Practice
por: Hong, A Ram, et al.
Publicado: (2019)